PRVA as reported
Privia Health Group, Inc. reported $2.36B of revenue over the trailing twelve months, +24% on the year before. 10 reported series are charted on this page, each one as filed.
$2.36B
Revenue, trailing twelve months · to Q2 2026 · +24% against the twelve months before
- Net Income
- $28M
Net Income · +90% year on year · trailing twelve months to Q2 2026
- Op Margin
- 1.9%
Op Margin · trailing twelve months to Q2 2026
- EPS
- $0.21
EPS · +91% year on year · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $2.36B | +24% | Q2 2026 |
| Net Income | $28M | +90% | Q2 2026 |
| EPS | $0.21 | +91% | Q2 2026 |
| Op Margin | 1.9% | n/a | Q2 2026 |
| Net Margin | 1.2% | n/a | Q2 2026 |
| ROE | 3.0% | n/a | Q2 2026 |
| ROA | 1.6% | n/a | Q2 2026 |
| ROIC | −45% | n/a | Q4 2022 · 14 quarters behind |
| Free Cash Flow | $81M | n/a | Q4 2023 · 10 quarters behind |
| P/E | 100 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Privia Health Group, Inc. (PRVA) - Revenue & ProfitRevenue & ProfitPrivia Health Group, Inc. (PRVA)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Health Information Services
Ranks #13 of 14 by Smart Score